Article

Use of complementary and alternative medicine in recurrent vulvovaginal candidiasis-Results of a practitioner survey

General Practice and Primary Health Care Academic Centre, University of Melbourne, Australia.
Complementary therapies in medicine (Impact Factor: 2.22). 08/2012; 20(4):218-21. DOI: 10.1016/j.ctim.2012.01.004
Source: PubMed

ABSTRACT The mainstream long term management of recurrent vulvovaginal candidiasis (RVVC) often results in poor outcomes. It is expensive and unacceptable for many women who therefore have incorporated complementary and alternative medicine (CAM) into their personal care plan.
To ascertain clinicians' knowledge of CAM and their recommendations for the use of CAM and non-pharmacological management in women with RVVC.
Anonymous, single page, self completed survey using convenience sampling at a vulval disorders meeting in New South Wales, Australia in 2009.
Sixty six health professionals (medical practitioners, dermatologists, nurses and allied health professionals).
Most clinicians reported asking about their patients' use of CAM and non-pharmacological management of RVVC, although only around half reported recommending it. CAM management included lactobacillus, oral and vaginal yoghurt, vinegar, garlic, Chinese medicine and tea-tree oil. Non-pharmacological management included dietary changes and use of cotton undergarments. Lactobacillus was the most commonly recommended CAM.
CAM is popular with patients and many clinicians actively recommend its use in RVVC despite limited supporting evidence. Further research in the area of CAM and RVVC is long overdue.

1 Follower
 · 
86 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background. Mixed methods research uses qualitative and quantitative methods together in a single study or a series of related studies. Objectives. To review the prevalence and quality of mixed methods studies in complementary medicine. Methods. All studies published in the top 10 integrative and complementary medicine journals in 2012 were screened. The quality of mixed methods studies was appraised using a published tool designed for mixed methods studies. Results. 4% of papers (95 out of 2349) reported mixed methods studies, 80 of which met criteria for applying the quality appraisal tool. The most popular formal mixed methods design was triangulation (used by 74% of studies), followed by embedded (14%), sequential explanatory (8%), and finally sequential exploratory (5%). Quantitative components were generally of higher quality than qualitative components; when quantitative components involved RCTs they were of particularly high quality. Common methodological limitations were identified. Most strikingly, none of the 80 mixed methods studies addressed the philosophical tensions inherent in mixing qualitative and quantitative methods. Conclusions and Implications. The quality of mixed methods research in CAM can be enhanced by addressing philosophical tensions and improving reporting of (a) analytic methods and reflexivity (in qualitative components) and (b) sampling and recruitment-related procedures (in all components).
    Evidence-based Complementary and Alternative Medicine 12/2013; 2013:187365. DOI:10.1155/2013/187365 · 2.18 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Available literature concerning the epidemiologic or clinical features of vulvovaginal candidiasis commonly reports that: 75% of women will experience an episode of vulvovaginal candidiasis in their lifetimes, 50% of whom will experience at least a second episode, and 5-10% of all women will experience recurrent vulvovaginal candidiasis (>=4 episodes/1 year). In this debate we traced the three commonly cited statistics to their presumed origins. It is apparent that these figures were inadequately documented and lacked supporting epidemiologic evidence. Population-based studies are needed to make reliable estimates of the lifetime risk of vulvovaginal candidiasis and the proportion of women who experience recurrent candidiasis. The extent to which vulvovaginal candidiasis is a source of population-level morbidity remains uncertain.
    BMC Women's Health 03/2014; 14(1):43. DOI:10.1186/1472-6874-14-43 · 1.66 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Despite therapeutic advances candidiasis remains a common fungal infection most frequently caused by C. albicans and may occur as vulvovaginal candidiasis or thrush, a mucocutaneous candidiasis. Candidiasis frequently occurs in newborns, in immune-deficient people like AIDS patients, and in people being treated with broad spectrum antibiotics. It is mainly due to C. albicans while other species such as C. tropicalis, C. glabrata, C. parapsilosis and C. krusei are increasingly isolated. OTC antifungal dosage forms such as creams and gels can be used for the effective treatment of local candidiasis. Whereas, for preventing spread of the disease to deeper vital organs; candidiasis antifungal chemotherapy is preferred. Use of probiotics and development of novel vaccines is an advance approach for the prevention of candidiasis. Present review summarizes the diagnosis, current status and challenges in treatment and prevention of candidiasis with prime focus on host defense against candidiasis, advancements in diagnosis, probiotics role and recent progress in development of vaccines against candidiasis.
    03/2015; 15(1). DOI:10.2174/1871526515666150320162036